| [1] |
KANG JY, LEE JO. Structural biology of the Toll-like receptor family[J]. Annu Rev Biochem, 2011, 80: 917-941. DOI: 10.1146/annurevbiochem-052909-141507.
|
| [2] |
LOIARRO M, RUGGIERO V, SETTE C. Targeting TLR/IL-1R signalling in human diseases[J]. Mediators Inflamm, 2010: 674363. DOI: 10.1155/2010/674363.
|
| [3] |
D'ARPA P, LEUNG KP. Toll-like receptor signaling in burn wound healing and scarring[J]. Adv Wound Care (New Rochelle), 2017, 6(10): 330-343. DOI: 10.1089/wound.2017.0733.
|
| [4] |
RUSSO I, PENNA C, MUSSO T, et al. Platelets, diabetes and myocardial ischemia/reperfusion injury[J]. Cardiovasc Diabetol, 2017, 16(1): 71. DOI: 10.1186/s12933-017-0550-6.
|
| [5] |
YANG H, ZHOU H, ZHUANG L, et al. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of Toll-like receptor 4 signaling in mice[J]. Liver Transpl, 2017, 23(1): 63-74. DOI: 10.1002/lt.24628.
|
| [6] |
RAO J, QIAN X, LI G, et al. ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/ reperfusion injury[J]. Am J Transplant, 2015, 15(1): 76-87. DOI: 10.1111/ajt.12954.
|
| [7] |
KAMO N, KE B, GHAFFARI AA, et al. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury[J]. Hepatology, 2013, 58(1): 351-362. DOI: 10.1002/hep.26320.
|
| [8] |
HUANG HF, ZENG Z, WANG KH, et al. Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways[J]. World J Gastroenterol, 2015, 21(10): 2937-2948. DOI: 10.3748/wjg.v21.i10.2937.
|
| [9] |
LIU QS, CHENG ZW, XIONG JG, et al. Erythropoietin pretreatment exerts anti-inflammatory effects in hepatic ischemia/reperfusion-injured rats via suppression of the TLR2/NF-κB pathway[J]. Transplant Proc, 2015, 47(2): 283-289. DOI: 10.1016/j.transproceed.2014.10.045.
|
| [10] |
YAMAMOTO T, TAJIMA Y. HMGB1 is a promising therapeutic target for acute liver failure[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(7): 673-682. DOI: 10.1080/17474124.2017.1345625.
|
| [11] |
LEEMANS JC, STOKMAN G, CLAESSEN N, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney[J]. J Clin Invest, 2005, 115(10): 2894-2903. doi: 10.1172/JCI22832
|
| [12] |
SELEJAN S, PÖSS J, WALTER F, et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenicshock[J]. Eur Heart J, 2012, 33(9): 1085-1094. DOI: 10.1093/eurheartj/ehr377.
|
| [13] |
ARSLAN F, HOUTGRAAF JH, KEOGH B, et al. Treatment with OPN-305, a humanized anti-Toll-like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs[J]. Circ Cardiovasc Interv, 2012, 5(2): 279-287. DOI: 10.1161/CIRCINTERVENTIONS.111.967596.
|
| [14] |
MERSMANN J, ISKANDAR F, LATSCH K, et al. Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is Toll-like receptor 2-dependent[J]. Mediators Inflamm, 2013: 174168. DOI: 10.1155/2013/174168.
|
| [15] |
HOFFMANN U, BERGLER T, RIHM M, et al. Impact of Toll-like receptor 2 expression in renal allograft rejection[J]. Nephrol Dial Transplant, 2011, 26(3): 1080-1087. DOI: 10.1093/ndt/gfq420.
|
| [16] |
FARRAR CA, KEOGH B, MCCORMACK W, et al. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemiareperfusion injury[J]. FASEB J, 2012, 26(2): 799-807. DOI: 10.1096/fj.11-195396.
|
| [17] |
LI Z, YANG N, ZHOU L, et al. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene[J]. Immunology, 2016, 147(3): 355-366. DOI: 10.1111/imm.12569.
|
| [18] |
CHI X, ZHANG A, LUO G, et al. Knockdown of myeloid differentiation protein-2 reduces acute lung injury following orthotopicautologous liver transplantation in a rat model[J]. Pulm Pharmacol Ther, 2013, 26(3): 380-387. DOI: 10.1016/j.pupt.2013.02.001.
|
| [19] |
MATSUOKA N, ITOH T, WATARAI H, et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice[J]. J Clin Invest, 2010, 120(3): 735-743. DOI: 10.1172/JCI41360.
|
| [20] |
KRÜGER B, YIN N, ZHANG N, et al. Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation[J]. Eur J Immunol, 2010, 40(10): 2914-2924. DOI: 10.1002/eji.201040601.
|
| [21] |
COOPER DK, DOU KF, TAO KS, et al. Pig liver xenotransplantation: a review of progress toward the clinic[J]. Transplantation, 2016, 100(10): 2039-2047. DOI: 10.1097/TP.0000000000001319.
|
| [22] |
王雨, 叶学军, 何盛南, 等.异种器官移植过程中预防T细胞排斥反应的研究进展[J].器官移植, 2017, 8(4): 324-327. DOI: 10.3969/j.issn.1674-7445.2017.04.016.
WANG Y, YE XJ, HE SN, et al. Research progress on the prevention of T cell rejection in xenotransplantation[J]. Organ Transplant, 2017, 8(4): 324-327. DOI: 10.3969/j.issn.1674-7445.2017.04.016.
|
| [23] |
RO H, LEE EW, HONG JH, et al. Roles of islet Toll-like receptors in pig to mouse islet xenotransplantation[J]. Cell Transplant, 2013, 22(9): 1709-1722. DOI: 10.3727/096368912X657684.
|
| [24] |
LI JH, ZHAO B, ZHU XH, et al. Blockade of extracellular HMGB1 suppresses xenoreactive B cell responses and delays acute vascular xenogeneic rejection[J]. Am J Transplant, 2015, 15(8): 2062-2074. DOI: 10.1111/ajt.13275.
|
| [25] |
RAU CS, LIN MW, WU SC, et al. Regulatory and effector helper T-cell profile after nerve xenografting in the Toll-like receptor-deficient mice[J]. Int J Med Sci, 2015, 12(8): 650-654. DOI: 10.7150/ijms.12304.eCollection 2015.
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: